1-2 of 2
Jerome Fischer
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Vardenafil, a New Phosphodiesterase Type 5 Inhibitor, in the Treatment of Erectile Dysfunction in Men With Diabetes: A multicenter double-blind placebo-controlled fixed-dose study

Irwin Goldstein, MD, Jay M. Young, MD, Jerome Fischer, MD, Keith Bangerter, PHD, Thomas Segerson, MD, Terry Taylor, MD, The Vardenafil Diabetes Study Group
Journal: Diabetes Care
Diabetes Care 2003;26(3):777–783
https://doi.org/10.2337/diacare.26.3.777
Published: 01 March 2003
View article titled, Vardenafil, a New Phosphodiesterase Type 5 Inhibitor, in the Treatment of Erectile Dysfunction in Men With Diabetes: <subtitle>A multicenter double-blind placebo-controlled fixed-dose study</subtitle>
Open the PDF for Vardenafil, a New Phosphodiesterase Type 5 Inhibitor, in the Treatment of Erectile Dysfunction in Men With Diabetes: <subtitle>A multicenter double-blind placebo-controlled fixed-dose study</subtitle> in another window
Journal Articles

Efficacy and Safety of Acarbose in Metformin-Treated Patients With Type 2 Diabetes

Julio Rosenstock, MD, Ann Brown, MD, Jerome Fischer, MD, Adesh Jain, MD, Thomas Littlejohn, MD, Dan Nadeau, MD, Allen Sussman, MD, Terry Taylor, MD, Alice Krol, MS, James Magner, MD
Journal: Diabetes Care
Diabetes Care 1998;21(12):2050–2055
https://doi.org/10.2337/diacare.21.12.2050
Published: 01 December 1998
View article titled, Efficacy and Safety of Acarbose in Metformin-Treated Patients With Type 2 Diabetes
Open the PDF for Efficacy and Safety of Acarbose in Metformin-Treated Patients With Type 2 Diabetes in another window